Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S375000, C548S170000, C548S217000
Reexamination Certificate
active
10970064
ABSTRACT:
A compound having Formula Iin-line-formulae description="In-line Formulae" end="lead"?R1—Z—R2Formula Iin-line-formulae description="In-line Formulae" end="tail"?wherein R1is an optionally substituted phenyl ring; R2is or comprises an optionally substituted aromatic ring; and Z is —X—Y—L— or —Y—X—L— wherein either X is selected from —S(═O)(═O)— and —C(═O)—; and Y is —NR3—; or X is selected from —S(═O)(═O)— and —S—, and Y is —C(R4)(R5)—; L is an optional linker; and R3, R4and R5are each independently selected from H and hydrocarbyl; and wherein when R2comprises the following structural moietywherein Q is an atom selected from the group consisting of S, O, N and C; the compound is selected from compounds of the formulae R1—C(═O)—NR3—L—R2; R1—S(═O)(═O)—C(R4)(R5)—L—R2; R1—S—C(R4)(R5)—L—R2; R1—NR3—S(═O)(═O)—L—R2; R1—NR3—C(═O)—L—R2; R1—C(R4)(R5)—S(═O)(═O)—L—R2; and R1—C(R4)(R5)—S—L—R2.
REFERENCES:
patent: 4659738 (1987-04-01), Miller et al.
patent: 2004/0137472 (2004-07-01), Kole
patent: 1 378 751 (2004-01-01), None
patent: 822947 (1959-11-01), None
patent: 828963 (1960-02-01), None
patent: 1198941 (1970-07-01), None
patent: WO 01/90090 (2001-11-01), None
patent: WO 01/90092 (2001-11-01), None
patent: WO 03/043999 (2003-05-01), None
patent: WO 03/044000 (2003-05-01), None
patent: WO 03/044009 (2003-05-01), None
Sener et al., “Synthesis and microbiological activity of some novel 5-benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole derivatives,” IL Farmco, vol. 55, pp. 397-405 (2000).
Sener E. A. et al.,Il Farmaco(2000) vol. 55 pp. 397-405.
Chan M. F. et al.,Bioorganic and Medical Chemistry Letters(1996) vol. 6, No. 20, pp. 2393-2398.
Stein P. D. et al.,J Medicinal Chemistry(1995) vol. 38 No. 8, pp. 1344-1354.
Hammond M.L. et al.,J Medicinal Chemistry(1990) vol. 33, No. 3, pp. 908-918.
Yoshida Y. et al.,Bioorganic and Medical Chemistry(1999) vol. 7, No. 11, pp. 2647-2666.
Grehn L et al.,Tetrahedron(1999) vol. 55, No. 15, pp. 4843-4852.
Database Beilstein: Beilstein Registry No. 6416404 (Abuzar et al.,Z. Naturforsch. B. Anorg. Chem. Org. Chem. (1981) vol. 36, No. 1, pp. 108-111).
Database Beilstein: Beilstein Registry No. 2784754 (2001).
Jensen K.A. et al.,Acta Chemica Scandinavica(1974) vol. 28, pp. 1-4.
Ganeshapillai Dharshini
Lloyd Potter Barry Victor
Purohit Atul
Reed Michael John
Vicker Nigel
Freistein Andrew B.
Saeed Kamal A.
Steptoe & Johnson LLP
Sterix Limited
LandOfFree
11β-hydroxysteroid dehydrogenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11β-hydroxysteroid dehydrogenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11β-hydroxysteroid dehydrogenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870218